Sopan Pharmaceuticals Limited’s Initial Public Offering (IPO) opens for subscription on Baisakh 3 and will close today, Baisakh 8, 2083. The company has issued a total of 3,474,900 shares for the general public.
Investors can apply for a minimum of 10 shares and a maximum of 11,000 shares. NMB Capital Limited is acting as the issue and sales manager for the IPO.
Earlier, the company had already allotted shares reserved for Nepali workers employed abroad. The Securities Board of Nepal (SEBON) had granted approval for the IPO issuance on Falgun 17.
According to CDSC data, by Monday evening, a total of 2,517,763 applicants had applied for the IPO. These applicants have submitted applications worth Rs. 2.88 arba, corresponding to 28,870,330 shares.
The IPO has been oversubscribed by 8.30 times compared to the total number of shares issued, indicating strong investor interest.
This article was originally published on https://bajarkochirfar.com. Translated with the help of AI and reviewed by our editorial team.
